샘플 요청 목록

 카트 문의
시장보고서
상품코드
1501109

세계의 암 줄기세포 시장

Cancer Stem Cells
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 89 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암 줄기세포(Cancer Stem Cells) 시장은 2030년까지 23억 달러에 달할 전망

2023년에 13억 달러로 추정된 암 줄기세포 시장은 2023-2030년 사이 CAGR 8.3%로 성장하고, 2030년에는 23억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 줄기세포 기반 암 치료는 CAGR7.7%를 차지하고 분석 기간 종료까지 13억 달러에 이를 것으로 예상됩니다. 표적암성 줄기세포 분절의 성장은 향후 7년간의 CAGR이 9.2%로 추정됩니다.

미국 시장은 3억 5,260만 달러로 추정, 중국은 CAGR 12.1%로 성장할 것으로 예측

미국의 암 줄기세포 시장은 2023년 3억 5,260달러로 추정되었습니다. 세계 2위 경제대국인 중국은 2023년부터 2030년까지 분석 기간 동안 CAGR 12.1%로 성장을 지속하여 2030년에는 5억 7,870만 달러 규모에 이를 것으로 예측됩니다. 다른 주목할만한 지역 시장으로는 일본과 캐나다가 있으며, 각각 2023-2030년 사이 4.5%와 7.5%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 5.2%로 성장할 것으로 예측됩니다.

2024년을 위한 새로운 보고서의 특징

  • 인플루언서의 참여 통계에 대한 전체 액세스 권한
  • 디지털 아카이브 및 'MarketGlass' 리서치 플랫폼에 무료로 액세스할 수 있습니다. 당사의 고유한 MarketGlass 플랫폼은 전 세계 전문가의 창의성과 시장 지식을 통합적이고 협업적으로 제공합니다. 당사의 최첨단 도구는 참가자의 프라이버시와 정체성을 보호하면서 세계 수준 시장 전망을 제공합니다. 이 보고서에 게재된 숫자, 통계 및 시장에 대한 설명은 이 분야의 전문가 및 인플루언서가 공유하는 완전한 검토 통찰력을 기반으로 합니다.
  • 실시간 데이터 시뮬레이터 도구와 맞춤형 보고 기능을 갖춘 대화형 설문조사에 참여할 수 있습니다.
  • 기업간의 스마트한 의견 교환을 위한 피어 콜라보레이티브 인터랙티브 플랫폼에 대한 전체 클라이언트 액세스 권한 제공
  • 1년간의 무료 보고서 업데이트
  • 주요 기업 시장 점유율을 포함한 경쟁 적용 범위
  • 복수의 지역에 걸치는 기업 시장 프레즌스 분석(강세/활발/틈새/미미)
  • 전문가/인플루언서 인터뷰, 팟캐스트, 프레스 발표, 이벤트 기조 강연의 YouTube 동영상에 대한 액세스

2024년 세계경제에 기대

금융 계약과 그에 따른 금리 상승으로 인한 지정학적 영향과 경제 불안정성은 2024년 세계 경제에 파란을 초래할 것으로 전망됩니다. 중동의 적대 행위와 점점 더 자주 발생하는 기후 재해와 같은 몇 가지 요인이 회복의 길에 압력을 가할 것입니다. 위험에 반해, 디스플레이션의 징후가 강해지고, 완고한 인플레이션에 대한 불안이 완화되고, 공급 체인이 정상화되고, 에너지 비용의 변동에도 불구하고 물가가 완만해지는 등, 몇 가지 플러스 재료도 구체화 계속 있습니다. 인도와 미국을 포함한 G21 국가의 선거는 자본 흐름과 투자 전략에 영향을 줄 수 있습니다. 인도가 세계적인 투자처로 주목받고 있는 한편, 미국을 거점으로 하는 하이테크 기업은 재능과 자본의 역동적인 에코시스템에 힘입어 계속 우위를 유지할 것으로 보입니다. 실리콘밸리를 비롯한 하이테크 기회는 국내 경제가 감속하고 있다고는 해도 견고하고 규제 환경도 정비되어 있기 때문에 고성장 가능성을 요구하는 투자자에게 계속 매력적입니다. 유럽은 금융 계약 정책과 경기 후퇴 위험 간의 싸움이 계속되지만 영국은 전망이 가장 엄격하며 2024년경기 후퇴 위험이 가장 높습니다. 중국은 정부 지출과 개인 소비 개선에 뒷받침된 성장이 기대되는 것, 계속 와일드카드가 됩니다. 불안정한 환경은 투자자와 기업 모두에게 기회와 도전을 모두 가져올 것으로 보입니다. 성장에 대한 촉매제로서 변동성을 받아들이는 것과 동시에 민첩성과 전략적 선견성으로 투자 판단에 임하는 것이 생존을 위해 중요하다는 것에 변함이 없습니다.

조사 대상 기업 예(전 33건)

  • AbbVie, Inc.
  • Bionomics
  • BIOTIME, INC.
  • Irvine Scientific
  • LONZA
  • MacroGenics, Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • Oncomed Pharmaceuticals Inc
  • PromoCell GmbH
  • Sino Biological Inc
  • Stemline Therapeutics, Inc
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아 태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아 태평양
  • 남미
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 남미
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LYJ

Global Cancer Stem Cells Market to Reach $2.3 Billion by 2030

The global market for Cancer Stem Cells estimated at US$1.3 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 8.3% over the period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record 7.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Targeted Cancerous Stem Cells segment is estimated at 9.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $352.6 Million, While China is Forecast to Grow at 12.1% CAGR

The Cancer Stem Cells market in the U.S. is estimated at US$352.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$578.7 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 7.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 33 Featured) -

  • AbbVie, Inc.
  • Bionomics
  • BIOTIME, INC.
  • Irvine Scientific
  • LONZA
  • MacroGenics, Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • Oncomed Pharmaceuticals Inc
  • PromoCell GmbH
  • Sino Biological Inc
  • Stemline Therapeutics, Inc
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cancer Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cancer Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cancer Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cancer Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Stem Cell-based Cancer Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Stem Cell-based Cancer Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Stem Cell-based Cancer Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Targeted Cancerous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Targeted Cancerous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Targeted Cancerous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Brain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Bladder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Bladder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Bladder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Cancer Stem Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • JAPAN
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • CHINA
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • EUROPE
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Cancer Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Cancer Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Cancer Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • FRANCE
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • GERMANY
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Cancer Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Cancer Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • INDIA
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Cancer Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Cancer Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Cancer Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Cancer Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Cancer Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Cancer Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030
  • AFRICA
    • Cancer Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Cancer Stem Cells by Mode Of Action - Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Cancer Stem Cells by Mode Of Action - Percentage Breakdown of Value Sales for Stem Cell-based Cancer Therapy and Targeted Cancerous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Cancer Stem Cells by Form - Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Cancer Stem Cells by Form - Percentage Breakdown of Value Sales for Other Forms, Breast, Blood, Lung, Brain, Colorectal, Pancreatic and Bladder for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제